Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

352
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
352

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Triphenylphosphonium compounds preferentially inhibit long-chain fatty acid oxidation in cardiac mitochondria.

Research square·2026
Same author

Insulin plant (Costus igneus) extract alleviates steatosis and adiposity in a murine MASLD model by modulating hepatic lipogenesis and the CD9-CFD immunoregulatory axis.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

A novel pharmacological inhibitor of MAP4K4 activity attenuates metabolic dysfunction-associated steatohepatitis.

JHEP reports : innovation in hepatology·2026
Same author

Cardiotropic ligand-guided liposomes for myocardial delivery of atorvastatin in a mouse model of myocardial infarction.

International journal of pharmaceutics·2025
Same author

Chronic β3 adrenergic agonist treatment improves neurovascular coupling responses, attenuates blood-brain barrier leakage and neuroinflammation, and enhances cognition in aged mice.

Aging·2025
Same author

Quantum Dot Erythropoietin Bioconjugates Enhance EPO-Receptor Clustering on Transfected Human Embryonic Kidney Cells.

Bioconjugate chemistry·2025

Related Experiment Video

Updated: May 5, 2026

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
09:45

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering

Published on: March 17, 2023

3.6K

Surface engineering of liposomes for stealth behavior.

Okhil K Nag1, Vibhudutta Awasthi

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Oklahoma Health Sciences Center, 1110 North Stonewall Avenue, Oklahoma City, OK 73117, USA. vawasthi@ouhsc.edu.

Pharmaceutics
|December 5, 2013
PubMed
Summary
This summary is machine-generated.

Researchers are exploring new materials to improve liposome drug delivery systems. Alternatives to poly(ethylene glycol)-linked phospholipids (PEG-PLs) offer enhanced stability and reduced immune response for better stealth properties.

More Related Videos

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

27.0K
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

8.9K

Related Experiment Videos

Last Updated: May 5, 2026

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
09:45

On-Chip Octanol-Assisted Liposome Assembly for Bioengineering

Published on: March 17, 2023

3.6K
Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins
11:30

Preparation and Characterization of Nanoliposomes for the Entrapment of Bioactive Hydrophilic Globular Proteins

Published on: August 31, 2019

27.0K
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
09:51

Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes

Published on: March 3, 2020

8.9K

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Pharmaceutical Sciences

Background:

  • Liposomes are crucial drug delivery vehicles, but conventional formulations face rapid clearance by the mononuclear phagocyte system.
  • Surface modification with hydrophilic polymers, like poly(ethylene glycol)-linked phospholipids (PEG-PLs), creates 'stealth' liposomes to prolong circulation.
  • PEG-PLs have limitations including immunogenicity and suboptimal drug loading, prompting research into alternatives.

Purpose of the Study:

  • To review emerging materials for liposome surface engineering as alternatives to PEG-PLs.
  • To highlight novel stealth lipopolymers offering improved characteristics over traditional PEG-based systems.
  • To discuss the advantages of non-phospholipid and PEG-alternative stealth lipopolymers.

Main Methods:

  • Review of scientific literature on liposome surface modification materials.
  • Analysis of the properties and applications of PEG-PLs and their alternatives.
  • Comparison of stealth lipopolymers based on structural versatility, stability, and biological impact.

Main Results:

  • Poly(ethylene glycol)-linked phospholipids (PEG-PLs) are widely used but exhibit drawbacks like immunogenicity.
  • Novel stealth lipopolymers utilizing non-phospholipids and PEG alternatives are emerging.
  • These new materials offer potential benefits such as reduced complement activation and enhanced stability.

Conclusions:

  • Alternative stealth lipopolymers present a promising avenue for advanced liposome drug delivery.
  • These novel materials may overcome the limitations associated with PEG-PLs, improving drug targeting and efficacy.
  • Further research into these materials could lead to more effective and safer liposomal therapeutics.